The effects of reduction mammaplasty (RM) have been proved in several randomised trials. However, publications regarding cost utility are infrequent and lacking with regard to medium-term follow-up. Therefore, we decided to assess the cost utility of RM at 2–5 years’ follow-up, when later costs and possible re-operations have been incurred.
A total of 73 patients had bilateral RM between January 2005 and March 2007 in the Hospital District of Helsinki and Uusimaa, Finland. Health-related quality of life was measured with the 15D. Preoperative data were collected with an interview at an appointment and follow-up data by means of a postal survey. Direct hospital costs were obtained from the Ecomed® clinical patient administration database (Datawell Ltd., Espoo, Finland).
A total of 62 (85%) patients agreed to participate in the study and returned the follow-up questionnaire. The mean follow-up time was 4.0 years (SD 0.53, range 2.3–4.6 years). The mean improvement in the 15D score change was 0.083 (SD 0.081). The mean number of quality-adjusted life years (QALYs) gained was 3.052 (SD 3.167, range 2.561–17.553). The mean hospital costs of the intervention were €3601 (SD 1321), and the mean cost per QALY gained was €1180. Roughly 76% of the costs were due to the hospital stay during the operation. Eight percent of the costs were incurred more than 6 months after the hospital stay.
The cost per QALY gained by RM is low, even when considering later costs caused by possible re-operations, and compares favourably with a number of other surgical procedures.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Journal of Plastic, Reconstructive & Aesthetic Surgery
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Reduction mammaplasty is effective treatment according to two quality of life instruments. A prospective randomised clinical trial.J Plast Reconstr Aesthet Surg. 2008; 61: 1472-1478
- Breast reduction alleviates depression and anxiety and restores self-esteem: a prospective randomised clinical trial.Scand J Plast Reconstr Surg Hand Surg. 2009; 43: 320-324
- Randomized clinical trial examining psychosocial and quality of life benefits of bilateral breast reduction surgery.Br J Surg. 2006; 93: 291-294
- Effects of bilateral breast reduction on anxiety and depression: results of a prospective randomised trial.Scand J Plast Reconstr Surg Hand Surg. 2006; 40: 19-23
- Functional capacity and postural pain outcomes after reduction mammaplasty.Plast Reconstr Surg. 2007; 119 (discussion 57–8): 1149-1156
- Self-esteem and functional capacity outcomes following reduction mammaplasty.Aesthetic Surg J. 2008; 28: 417-420
- Cost-effectiveness of reduction mammaplasty.Int J Technol Assess Health Care. 2004; 20: 269-273
- Cost-utility of breast reduction surgery – A prospective study.J Plast Reconstr Aesthet Surg. 2010; 63: 87-92
- What’s the evidence that NICE guidance has been implemented? More recent data on NICE implementation show different picture.BMJ. 2005; 330 (discussion 86): 1086
- National Institute for Clinical Excellence and its value judgments.BMJ. 2004; 329: 224-227
- NICE discrimination.J Med Ethics. 2005; 31 (discussion 85–8): 683-684
- Searching for cost effectiveness thresholds in the NHS.Health Policy. 2009; 91: 239-245
- Evidence, ethics and inclusion: a broader base for NICE.Med Health Care Philos, 2010
- Three-year follow-up on clinical symptoms and health-related quality of life after reduction mammaplasty.Plast Reconstr Surg. 2004; 114: 49-54
- Changes in body image and health-related quality of life following breast reduction surgery in German macromastia patients: a new tool for measuring body image changes.Ann Plast Surg. 2007; 58: 364-370
- The outcome of reduction mammaplasty remains stable at 2–5 years' follow-up: A prospective study.J Plast Reconstr Aesthet Surg. 2011; 64: 573-576
- The 15D instrument of health-related quality of life: properties and applications.Ann Med. 2001; 33: 328-336
- A comparison of the Assessment of Quality of Life (AQoL) with four other generic utility instruments.Ann Med. 2001; 33: 358-370
- The 15-D measure of health-related quality of life: II Feasibility, reliability and validity of its valuation system.(Working Paper 42) National Centre for Health Program Evaluation. National Health and Medical Research Council.1995, MelbourneMarch 5, 2011Available from Accessibility verified)
- Reliability, validity and responsiveness of two multiattribute utility measures in patients with chronic obstructive pulmonary disease.Qual Life Res. 1999; 8: 45-54
- Comparing preference-based quality-of-life measures: results from rehabilitation patients with musculoskeletal, cardiovascular, or psychosomatic disorders.Qual Life Res. 2008; 17: 485-495
Finnish Ministry of Social Affairs and Health. Recommendations for health economical analysis. Available at: www.finlex.fi/fi/laki/alkup/2009/20090201. Accessed February 2011.
- Chronic pain in women after breast augmentation: prevalence, predictive factors and quality of life.Eur J Pain. 2009; 13: 660-661
- Symptoms and related severity experienced by women with breast hypertrophy.Plast Reconstr Surg. 2007; 119: 481-486
- Outcomes in breast reduction surgery.Ann Plast Surg. 2000; 45: 575-580
- A prospective study of patients undergoing breast reduction surgery: health-related quality of life and clinical outcomes.Plast Reconstr Surg. 2007; 120: 13-26
- Effectiveness of superficial venous surgery in terms of quality-adjusted life years and costs.Scand J Surg. 2009; 98: 229-233
- Cost-utility of routine cataract surgery.Health Qual Life Outcomes. 2006; 4: 74
- Cost-utility analysis of routine neurosurgical spinal surgery.J Neurosurg Spine. 2006; 5: 204-209
- Effectiveness of hip or knee replacement surgery in terms of quality-adjusted life years and costs.Acta Orthop. 2007; 78: 108-115
- Does NICE have a cost-effectiveness threshold and what other factors influence its decisions? A binary choice analysis.Health Econ. 2004; 13: 437-452
- The impact of 29 chronic conditions on health-related quality of life: a general population survey in Finland using 15D and EQ-5D.Qual Life Res. 2006; 15: 1403-1414
Published online: August 29, 2011
Accepted: July 22, 2011
Received: March 24, 2011
© 2011 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Inc. All rights reserved.